Related Experiment Video
Updated: Sep 11, 2025

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
The multifaceted role of KIF15 in cancer progression and therapy
Sarah Qutayba Badraldin1, Karar H Alfarttoosi2, Hayder Naji Sameer3
1College of Pharmacy, Alnoor University, Nineveh, Iraq.
Abstract:
Kinesin family member 15 (KIF15), a kinesin superfamily motor protein, is known to be involved in mitotic spindle formation and chromosome movement during cell division. Recent research has determined KIF15 to be a crucial regulator in several oncogenic pathways and proposed that its role may extend beyond mere cell mechanics. Aberrant KIF15 expression has also been found to be involved in the onset of numerous cancers by promoting the proliferation, migration, and invasive abilities of cancer cells, thereby leading to increased metastatic capability. This review summarizes knowledge of the complex roles of KIF15 in cancer biology, highlighting its regulatory functions and interactions with key signaling pathways that control cell cycle kinetics and mechanisms for tumorigenesis. Moreover, the elevated levels of KIF15 in certain types of cancer make it an amenable target for therapy. New directions toward inhibiting activity or reducing the levels of KIF15 promise to restrict tumor growth, offering new hope for cancer treatment. This combined understanding of KIF15 functions stresses its importance not only in the fundamental processes of cell division but also in the developing field of cancer treatment, highlighting the ongoing necessity for extensive research into creating effective treatments targeted against KIF15 in oncology.
Insights
Kinesin family member 15 (KIF15) drives cancer progression and metastasis. Inhibiting KIF15 offers a promising therapeutic strategy to restrict tumor growth and improve cancer treatment outcomes.
Area of Science:
- Oncology
- Cell Biology
- Molecular Medicine
Background:
- Kinesin family member 15 (KIF15) is a motor protein vital for cell division.
- Aberrant KIF15 expression is linked to cancer onset, promoting proliferation, migration, and invasion.
- KIF15's role in oncogenic pathways extends beyond cell mechanics.
Purpose of the Study:
- To review the multifaceted roles of KIF15 in cancer biology.
- To highlight KIF15's regulatory functions and interactions with cancer-related signaling pathways.
- To explore KIF15 as a potential therapeutic target in oncology.
Main Methods:
- Literature review of KIF15 research in cancer biology.
- Analysis of KIF15's involvement in cell cycle regulation and tumorigenesis.
- Evaluation of KIF15 as a target for cancer therapeutics.
Main Results:
- KIF15 significantly influences cancer cell proliferation, migration, and metastasis.
- KIF15 interacts with key signaling pathways critical for tumor development.
- Elevated KIF15 levels in cancers present a therapeutic vulnerability.
Conclusions:
- KIF15 is crucial for both cell division and cancer progression.
- Targeting KIF15 offers a promising avenue for novel cancer therapies.
- Further research is essential for developing effective KIF15-targeted treatments.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

